MCAS, histamine and multisystem reactivity patterns

What records in this area tend to contain

These are descriptions of records, not diagnostic criteria. Recognising several of them does not mean you have a condition, and none of them is being asserted about you.

• Reactions to foods, medications, excipients, or supplements that do not follow one chemical class
• Flushing, itching, hives, throat tightness, or heat and alcohol intolerance
• Partial response to H1/H2 blockers or a stabiliser, with the underlying course unchanged
• Tryptase, histamine, or prostaglandin metabolite testing collected under unclear conditions
• Symptoms clustering with gut episodes, posture change, menstrual cycle, or infection
• A widening avoidance list that has not restored stability

The analytical work on a case like this

• Full reactivity chronology: what changed, when, and against which background events
• Mediator testing read with attention to collection conditions and interpretive limits
• Gut–immune interface considerations, including barrier and microbial contributions to threshold
• Autonomic overlap, since posture, adrenergic tone and mast cell behaviour interact
• Medication, excipient and supplement exposure as a structured list rather than anecdotes
• Hormonal, infectious, and environmental timing signals in the record

What the work is trying to answer

These are the questions the reconstruction is built around. They are questions, not promises — some records answer them clearly and some do not, and the written synthesis says which.

• Is the reactivity best read as a primary mast cell process, or as a threshold problem driven from elsewhere?
• What has been tested properly, and what has been asserted from symptoms alone?
• Which upstream candidates — barrier, microbial, autonomic, hormonal, exposure — the record actually supports
• What would a clinician need to see to accept or reject the leading explanation?

What would argue against the leading reading

Every synthesis states the alternatives it could not exclude. For this area, the most important ones are:

• IgE-mediated allergy, which requires allergology assessment rather than mechanistic inference
• Hereditary alpha tryptasemia or a clonal mast cell disorder, which are haematological questions
• Carbohydrate, salicylate, or FODMAP intolerance producing overlapping symptoms
• Anxiety and interoceptive amplification, which can coexist with a real mediator process
• Medication side effects, including from the agents used to treat the reactivity

Related reading on this site

• MCAS that doesn't respond to standard treatment
• Mast cell and histamine patterns
• When MCAS treatment fails
• Gut barrier dysfunction

• Mold, CIRS-related and environmental patterns

  For records built around a suspected exposure, where mycotoxin panels, inflammatory markers and competing frameworks have produced more conflict than clarity.

• Medication- and treatment-associated patterns

  For cases with a clear turning point after an antibiotic, a procedure, or a medication change, where the chronology has never been formally reconstructed.

• Complex food and chemical sensitivity

  For shrinking diets and growing reaction lists, where each new restriction buys less relief than the last.

All Areas of Analysis →